Large-scale expansion in interleukin-2 of tumor-infiltrating lymphocytes from patients with ovarian carcinoma for adoptive immunotherapy
- 1 January 1994
- journal article
- clinical trial
- Published by Elsevier BV in Journal of Immunological Methods
- Vol. 167 (1-2), 145-160
- https://doi.org/10.1016/0022-1759(94)90084-1
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Novel immunologic strategies in ovarian carcinomaAmerican Journal of Obstetrics and Gynecology, 1992
- γ/δ T cell antigen receptors expressed on tumor-infiltrating lymphocytes from patients with solid tumorsEuropean Journal of Immunology, 1992
- Human autologous tumor-specific T cells in malignant melanomaCancer and Metastasis Reviews, 1991
- Culture of human tumor infiltrating lymphocytes in hollow fiber bioreactorsJournal of Immunological Methods, 1990
- Use of Tumor-Infiltrating Lymphocytes and Interleukin-2 in the Immunotherapy of Patients with Metastatic MelanomaNew England Journal of Medicine, 1988
- Autologous tumor-specific cytotoxic T lymphocytes in the infiltrate of human metastatic melanomas. Activation by interleukin 2 and autologous tumor cells, and involvement of the T cell receptor.The Journal of Experimental Medicine, 1988
- Immunotherapy of patients with advanced cancer using tumor-infiltrating lymphocytes and recombinant interleukin-2: a pilot study.Journal of Clinical Oncology, 1988
- Development of an automated closed system for generation of human lymphokine-activated killer (LAK) cells for use in adoptive immunotherapyJournal of Immunological Methods, 1987
- A Progress Report on the Treatment of 157 Patients with Advanced Cancer Using Lymphokine-Activated Killer Cells and Interleukin-2 or High-Dose Interleukin-2 AloneNew England Journal of Medicine, 1987
- Recent Immunologic Advances Affecting the Management of Ovarian CancerClinical Obstetrics and Gynecology, 1985